{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:22:22Z","timestamp":1707524542841},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,9]]},"DOI":"10.7759\/cureus.24852","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T16:25:26Z","timestamp":1652113526000},"source":"Crossref","is-referenced-by-count":0,"title":["Evidence of Continued CD4+ and CD8+ T Cell Activity After SARS-COV-2 Clearance in a Late COVID-19 Pneumonia Heart Transplant Patient"],"prefix":"10.7759","author":[{"given":"Francisco R","family":"Klein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda F","family":"Renedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A","family":"Vigliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang C","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020, 395:497-506. 10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-020-02886-6","article-title":"Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists","volume":"477","author":"Calabrese F","year":"2020","unstructured":"Calabrese F, Pezzuto F, Fortarezza F, et al.. Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists. Virchows Arch. 2020, 477:359-72. 10.1007\/s00428-020-02886-6","journal-title":"Virchows Arch"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqab208","article-title":"Pulmonary pathology of end-stage COVID-19 disease in explanted lungs and outcomes after lung transplantation","author":"Flaifel A","year":"2022","unstructured":"Flaifel A, Kwok B, Ko J, et al.. Pulmonary pathology of end-stage COVID-19 disease in explanted lungs and outcomes after lung transplantation. Am J Clin Pathol. 2022, 10.1093\/ajcp\/aqab208","journal-title":"Am J Clin Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-020-02975-6","article-title":"Transbronchial biopsies' histopathological findings leading to successful late steroid therapy in COVID-19 acute respiratory failure","volume":"479","author":"Klein F","year":"2021","unstructured":"Klein F, Soriano JC, Anfuso MB, et al.. Transbronchial biopsies' histopathological findings leading to successful late steroid therapy in COVID-19 acute respiratory failure. Virchows Arch. 2021, 479:827-33. 10.1007\/s00428-020-02975-6","journal-title":"Virchows Arch"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000003523","article-title":"COVID-19 and solid organ transplantation: a review article","volume":"105","author":"Azzi Y","year":"2021","unstructured":"Azzi Y, Bartash R, Scalea J, Loarte-Campos P, Akalin E. COVID-19 and solid organ transplantation: a review article. Transplantation. 2021, 105:37-55. 10.1097\/TP.0000000000003523","journal-title":"Transplantation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.2159","article-title":"Characteristics and outcomes of recipients of heart transplant with coronavirus disease 2019","volume":"5","author":"Latif F","year":"2020","unstructured":"Latif F, Farr MA, Clerkin KJ, et al.. Characteristics and outcomes of recipients of heart transplant with coronavirus disease 2019. JAMA Cardiol. 2020, 5:1165-9. 10.1001\/jamacardio.2020.2159","journal-title":"JAMA Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2020.10.009","article-title":"COVID-19 in heart transplant recipients: a multicenter analysis of the northern Italian outbreak","volume":"9","author":"Bottio T","year":"2021","unstructured":"Bottio T, Bagozzi L, Fiocco A, et al.. COVID-19 in heart transplant recipients: a multicenter analysis of the northern Italian outbreak. JACC Heart Fail. 2021, 9:52-61. 10.1016\/j.jchf.2020.10.009","journal-title":"JACC Heart Fail"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000003908","article-title":"Two doses of SARS-CoV-2 vaccines reduce risk of death due to COVID-19 in solid organ transplant recipients: preliminary outcomes from a UK registry linkage analysis","volume":"105","author":"Ravanan R","year":"2021","unstructured":"Ravanan R, Mumford L, Ushiro-Lumb I, et al.. Two doses of SARS-CoV-2 vaccines reduce risk of death due to COVID-19 in solid organ transplant recipients: preliminary outcomes from a UK registry linkage analysis. Transplantation. 2021, 105:e263-4. 10.1097\/TP.0000000000003908","journal-title":"Transplantation"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Horby P","year":"2021","unstructured":"Horby P, Lim WS, Emberson JR, et al.. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021, 384:693-704. 10.1056\/NEJMoa2021436","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/his.14249","article-title":"Progression to fibrosing diffuse alveolar damage in a series of 30 minimally invasive autopsies with COVID-19 pneumonia in Wuhan, China","volume":"78","author":"Li Y","year":"2021","unstructured":"Li Y, Wu J, Wang S, et al.. Progression to fibrosing diffuse alveolar damage in a series of 30 minimally invasive autopsies with COVID-19 pneumonia in Wuhan, China. Histopathology. 2021, 78:542-55. 10.1111\/his.14249","journal-title":"Histopathology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-020-02934-1","article-title":"Fibrotic progression and radiologic correlation in matched lung samples from COVID-19 post-mortems","volume":"478","author":"Barisione E","year":"2021","unstructured":"Barisione E, Grillo F, Ball L, et al.. Fibrotic progression and radiologic correlation in matched lung samples from COVID-19 post-mortems. Virchows Arch. 2021, 478:471-85. 10.1007\/s00428-020-02934-1","journal-title":"Virchows Arch"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14032","article-title":"A proposed strategy for management of immunosuppression in heart transplant patients with COVID-19","volume":"34","author":"Ahluwalia M","year":"2020","unstructured":"Ahluwalia M, Givertz MM, Mehra MR. A proposed strategy for management of immunosuppression in heart transplant patients with COVID-19. Clin Transplant. 2020, 34:e14032. 10.1111\/ctr.14032","journal-title":"Clin Transplant"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-020-0603-3","article-title":"A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression","volume":"33","author":"Polak SB","year":"2020","unstructured":"Polak SB, Van Gool IC, Cohen D, von der Th\u00fcsen JH, van Paassen J. A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression. Mod Pathol. 2020, 33:2128-38. 10.1038\/s41379-020-0603-3","journal-title":"Mod Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18854-2","article-title":"Two distinct immunopathological profiles in autopsy lungs of COVID-19","volume":"11","author":"Nienhold R","year":"2020","unstructured":"Nienhold R, Ciani Y, Koelzer VH, et al.. Two distinct immunopathological profiles in autopsy lungs of COVID-19. Nat Commun. 2020, 11:5086. 10.1038\/s41467-020-18854-2","journal-title":"Nat Commun"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.09.027","article-title":"The potential indicators for pulmonary fibrosis in survivors of severe COVID-19","volume":"82","author":"Huang W","year":"2021","unstructured":"Huang W, Wu Q, Chen Z, Xiong Z, Wang K, Tian J, Zhang S. The potential indicators for pulmonary fibrosis in survivors of severe COVID-19. J Infect. 2021, 82:e5-7. 10.1016\/j.jinf.2020.09.027","journal-title":"J Infect"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/path.5642","article-title":"COVID-19: immunopathology, pathophysiological mechanisms, and treatment options","volume":"254","author":"van Eijk LE","year":"2021","unstructured":"van Eijk LE, Binkhorst M, Bourgonje AR, et al.. COVID-19: immunopathology, pathophysiological mechanisms, and treatment options. J Pathol. 2021, 254:307-31. 10.1002\/path.5642","journal-title":"J Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2020.03.012","article-title":"COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal","volume":"39","author":"Siddiqi HK","year":"2020","unstructured":"Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant. 2020, 39:405-7. 10.1016\/j.healun.2020.03.012","journal-title":"J Heart Lung Transplant"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12977","article-title":"COVID-19 and pulmonary fibrosis: a potential role for lung epithelial cells and fibroblasts","volume":"302","author":"John AE","year":"2021","unstructured":"John AE, Joseph C, Jenkins G, Tatler AL. COVID-19 and pulmonary fibrosis: a potential role for lung epithelial cells and fibroblasts. Immunol Rev. 2021, 302:228-40. 10.1111\/imr.12977","journal-title":"Immunol Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2021-218275","article-title":"Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis","author":"Fabbri L","year":"2022","unstructured":"Fabbri L, Moss S, Khan FA, et al.. Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis. Thorax. 2022, 10.1136\/thoraxjnl-2021-218275","journal-title":"Thorax"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101209","article-title":"Usual interstitial pneumonia is the most common finding in surgical lung biopsies from patients with persistent interstitial lung disease following infection with SARS-CoV-2","volume":"42","author":"Konopka KE","year":"2021","unstructured":"Konopka KE, Perry W, Huang T, Farver CF, Myers JL. Usual interstitial pneumonia is the most common finding in surgical lung biopsies from patients with persistent interstitial lung disease following infection with SARS-CoV-2. EClinicalMedicine. 2021, 42:101209. 10.1016\/j.eclinm.2021.101209","journal-title":"EClinicalMedicine"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/95624-evidence-of-continued-cd4-and-cd8-t-cell-activity-after-sars-cov-2-clearance-in-a-late-covid-19-pneumonia-heart-transplant-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:29Z","timestamp":1707507689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/95624-evidence-of-continued-cd4-and-cd8-t-cell-activity-after-sars-cov-2-clearance-in-a-late-covid-19-pneumonia-heart-transplant-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,9]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.24852","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,9]]}}}